Quick Answer
ALX ONCOLOGY HOLDINGS INC reported Net Income of -$101.69 million for fiscal year 2025.
ALX ONCOLOGY HOLDINGS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$101.69M | +24.6% |
| 2024 | -$134.85M | +16.1% |
| 2023 | -$160.81M | -30.2% |
| 2022 | -$123.48M | -47.9% |
| 2021 | -$83.46M | -82.5% |
| 2020 | -$45.74M | -137.7% |
| 2019 | -$19.24M | -40.1% |
| 2018 | -$13.73M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$22.14M | +27.9% | +14.7% |
| June 30, 2025 | -$25.95M | +34.1% | +15.6% |
| March 31, 2025 | -$30.75M | +13.6% | -0.2% |
| September 30, 2024 | -$30.71M | +39.8% | +22.1% |
| June 30, 2024 | -$39.40M | -15.3% | -10.7% |
| March 31, 2024 | -$35.58M | -17.9% | +30.2% |
| September 30, 2023 | -$50.99M | -44.4% | -49.3% |
| June 30, 2023 | -$34.16M | -3.8% | -13.2% |
- ALX ONCOLOGY HOLDINGS INC showed an increase of +24.6% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, ALX ONCOLOGY HOLDINGS INC’s net income has declined by 640.6% (from -$13.73 million to -$101.69 million).
- The most recent figure is from ALX ONCOLOGY HOLDINGS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: